Abstract Body

Background: We reported earlier that removal of a highly conserved N-linked glycan N197 (N7) on the primary HIV-1 isolate 89.6 improved the immunogenicity of the envelope (Env) protein. Deletion of this glycan made the 89.6 Env more sensitive to CD4-binding site-specificantibodies (Abs) and less dependent on the CD4 receptor to initiate infection. However, it is not clear if the improvement in immunogenicity of 89.6 Env is related to the N7 glycan site mutation per se or the acquisition of a partial CD4i phenotype.

Methods: Here, we generated fully CD4i viruses derived from the WT and the N7 mutant of SHIV 89.6 and isolated Env clones that are replication competent in CD4-negative cells. CD4-independece was confirmed by evaluation of cloned Envs in cell fusion assay and on infectious viruses when cloned back into SHIV backbone.
Then we generated recombinant vaccinia viruses expressing CD4i 89.6WT (i89.6WT) and N7 (i89.6N7) mutant Envs. Antigenicity of these Envs on cell surface was analyzed using flow cytometry. Neutralization sensitivity of CD4i SHIV viruses was tested on TZM-bl cells. Biological function of these CD4i 89.6 Envs was tested by cell fusion assay.

Results: We isolated two i89.6 WT Env clones (A2 and B1) and one i89.6N7 Env clone (D4t), which were derived, respectively, from WT and N7 versions of SHIV 89.6. i89.6 N7-D4t Env maintains an intact CD4 binding site (bs), but CD4bs of i89.6-A2 and -B1 Envs are mutated. Cytoplasmic tails of all three Envs are truncated. In contrast to parental 89.6 WT and N7 Envs, i89.6 WT and N7 Envs can medicate cell-cell fusion in CD4-negative CCR5- and/or CXCR4-expressing cells. Only SHIV i89.6 WT and N7 viruses replicate in those CD4-negative cells.
Recombinant vaccinia viruses expressing i89.6 WT and N7 were generated. Full length i89.6WT and N7 Envs can be expressed, glycosylated and processed into gp120 and gp41. i89.6WT and N7 Envs expressed by vaccinia virus vectors mediate cell fusion and exhibit antigenic properties expected of native Env trimers. They preserve epitopes of most broadly neutralizing Abs tested, but they also show altered antigenicity compared to parental Envs.

Conclusions: Acquisition of the CD4i phenotype is accompanied by changes in the receptor/coreceptor binding properties of the Env and its antigenicity. How these changes may impact the immunogenicity of Env is being examined.